Hypercholesterolemia
Hypercholesterolemia, wanda kuma ake kira high cholesterol, shine kasancewar yawan matakan cholesterol a cikin jini.[1] Yana da nau'in lipids na jini mara kyau, tare da high triglycerides da low HDL cholesterol.[2][3] Gabaɗaya babu alamun bayyanar.[4] A lokuta masu tsanani xanthomas na iya faruwa.[1] Matsalolin na iya haɗawa da cututtukan zuciya, bugun jini, da cututtukan jijiyoyin jini.[5]
| Hypercholesterolemia | |
|---|---|
Description (en)  | |
| Iri |
hyperlipidemia (en) |
| Specialty (en) |
endocrinology (en) |
| Genetic association (en) |
CLQTL2 (en) |
| Medical treatment (en) | |
| Magani |
fluvastatin (en) |
| Identifier (en) | |
| ICD-10 | E78.0 |
| ICD-9 | 272.0 |
| DiseasesDB | 6226 |
| MedlinePlus | 000403 |
| eMedicine | 000403 |
| MeSH | D006937 |
Dalilan na iya haɗawa da cututtukan ƙwayoyin cuta kamar hypercholesterolemia na iyali.[5] Yawancin lokuta; duk da haka, sun kasance saboda haɗuwa da abubuwan da ke tattare da kwayoyin halitta tare da abinci, rashin aiki, kiba da shan taba.[5][4] Sauran abubuwan haɗari sun haɗa da ƙananan thyroid, ciwon nephrotic, cholestasis, barasa, ciwon sukari, da wasu magunguna kamar HCTZ.[5][1] Bincike ya dogara ne akan gwaje-gwajen jini don gano babban adadin cholesterol ko LDL cholesterol.[6][1]
Jiyya yawanci ya ƙunshi canje-canjen salon rayuwa da magunguna.[4] Canje-canjen salon rayuwa sun haɗa da motsa jiki da abinci mai kyau.[1] Idan canje-canjen salon rayuwa bai wadatar ba, ana ba da shawarar magungunan statin sau da yawa.[4] Sauran magungunan da za a iya amfani da su sun haɗa da ezetimibe, niacin, da masu hana PCSK9.[5] Ba kasafai ake yin apheresis na LDL ko dashen hanta ba.[7]
An kiyasta yawan cholesterol yana shafar kusan kashi 39% na mutane a duniya.[8] Kimanin manya miliyan 74 (32%) a Amurka suna da babban cholesterol.[5] Hypercholesterolemia na iyali yana shafar kusan 1 cikin mutane 250.[5] Tsofaffi sun fi shafa.[4] A duk duniya an kiyasta cewa yana haifar da mutuwar mutane kusan miliyan 2.6 a kowace shekara.[8] An fara bayyana hypercholesterolemia na iyali a cikin 1938.[9]
Manazarta
gyara sashe- ↑ 1.0 1.1 1.2 1.3 1.4 "Quick Facts: High Cholesterol". Merck Manuals Consumer Version. Retrieved 8 March 2021.
- ↑ Pappan, N; Rehman, A (January 2021). "Dyslipidemia". PMID 32809726. Cite journal requires
|journal=(help) - ↑ "Hypercholesterolemia - Symptoms, diagnosis and treatment | BMJ Best Practice US". bestpractice.bmj.com. Retrieved 8 March 2021.
- ↑ 4.0 4.1 4.2 4.3 4.4 "Cholesterol". medlineplus.gov. Retrieved 8 March 2021.
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 Ibrahim, MA; Asuka, E; Jialal, I (January 2021). "Hypercholesterolemia". PMID 29083750. Cite journal requires
|journal=(help) - ↑ "Hypercholesterolemia - Symptoms, diagnosis and treatment | BMJ Best Practice US". bestpractice.bmj.com. Retrieved 8 March 2021.
- ↑ Ito MK, McGowan MP, Moriarty PM (June 2011). "Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia". J Clin Lipidol. 5 (3 Suppl): S38–45. doi:10.1016/j.jacl.2011.04.001. PMID 21600528.
- ↑ 8.0 8.1 Noubiap, JJ; Nansseu, JR; Bigna, JJ; Jingi, AM; Kengne, AP (17 March 2015). "Prevalence and incidence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis protocol". BMJ open. 5 (3): e007404. doi:10.1136/bmjopen-2014-007404. PMID 25783427.
- ↑ Januzzi, James L. (2011). Cardiac Biomarkers in Clinical Practice (in Turanci). Jones & Bartlett Learning. p. 786. ISBN 978-0-7637-6161-5.